{
  "main_header": {
    "sid": 1003507,
    "name": "Walpar Nutrition",
    "stock_name": "Walpar Nutrition",
    "full_name": "Walpar Nutritions Ltd",
    "name_url": "stocks-analysis/walpar-nutrition",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "46.40",
    "chg": 2.15,
    "chgp": "4.86%",
    "dir": 1,
    "prev_price": "44.25",
    "mcapval": "44.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "WALPAR",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE0G2G01015",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": 2000,
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/walpar-nutrition-1003507-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Walpar Nutrition falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-walpar-nutrition-fallingrising-3722280",
        "imagepath": "",
        "date": "2025-11-22 01:26:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Stock Performance Against Benchmarks</strong></p>\n<p>Walpar Nutritions has experienced a sustained period of negative returns when compared to the broader Sensex index. Over the past week, the stock has declined by 10.71%, sharply contrasting with the Sensex's modest gain of 0.61%. This underperformance extends over longer horizons as well, with the stock down 14.56% in the last month while the Sensex rose by 0.77%. Year-to-date figures further highlight this divergence, with Walpar Nutritions falling 21.58% against the Sensex's 10.25% gain. Even over a one-year period, the stock remains down 13.91%, whereas the Sensex has appreciated by 11.64%. These figures underscore a persistent weakness in the stock relative to the broader market.</p>\n<p><strong>Proximity to 52-Week Low and Technical In..."
      },
      {
        "title": "Why is Walpar Nutrition falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-walpar-nutrition-fallingrising-3713427",
        "imagepath": "",
        "date": "2025-11-18 23:55:24",
        "description": "As of 18-Nov, Walpar Nutritions Ltd is experiencing a decline in its stock price, currently at 42.15, which reflects a decrease of 2.2 or 4.96%. The stock has underperformed its sector by 4.54% today and is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a return of -8.17%, and for the month, it has dropped by 7.87%. Despite a notable increase in delivery volume by 150% on November 14, indicating rising investor participation, the overall performance remains weak, with a year-to-date decline of 16.53%.\n\nIn the broader market context, the Sensex has shown resilience with a positive return of 0.84% over the past week and 0.78% over the past month, contrasting sharply with Walpar's negative performance. While the stock has outperformed the benchmark over a three-year period with a return of 58.31%, its recent trends suggest a significan..."
      },
      {
        "title": "Is Walpar Nutrition overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-walpar-nutrition-overvalued-or-undervalued-3709944",
        "imagepath": "",
        "date": "2025-11-18 08:25:16",
        "description": "As of 17 November 2025, the valuation grade for Walpar Nutrition has moved from attractive to very attractive, indicating a strong positive shift in its valuation outlook. The company is currently assessed as undervalued. Key ratios include a PE ratio of 24.64, an EV to EBITDA of 14.13, and a PEG ratio of 0.47, which suggests that the stock is priced favorably relative to its growth prospects.\n\nIn comparison to its peers, Walpar Nutrition stands out with its lower valuation metrics; for instance, Hindustan Unilever has a PE ratio of 53.89 and an EV to EBITDA of 38.18, while Nestle India shows a PE of 81.88. This positions Walpar Nutrition as a more attractive investment opportunity within the FMCG sector. Despite recent underperformance against the Sensex, with a year-to-date return of -12.18% compared to the Sensex's 10.02%, the company's strong fundamentals and favorable valuation ratios suggest potential..."
      },
      {
        "title": "How has been the historical performance of Walpar Nutrition?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-walpar-nutrition-3699718",
        "imagepath": "",
        "date": "2025-11-13 23:47:41",
        "description": "Answer:\nThe historical performance of Walpar Nutrition shows significant growth in net sales and profitability over the years.\n\nBreakdown:\nWalpar Nutrition's net sales have increased from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25, demonstrating a robust upward trend. The total operating income followed a similar trajectory, rising from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25. Raw material costs have also escalated, from 4.56 Cr in Mar'21 to 56.89 Cr in Mar'25, reflecting the company's expanding operations. Operating profit (PBDIT) has improved from 0.46 Cr in Mar'21 to 5.99 Cr in Mar'25, while profit before tax has surged from 0.16 Cr to 3.88 Cr during the same period. Profit after tax has risen from 0.15 Cr in Mar'21 to 2.80 Cr in Mar'25, indicating enhanced profitability. The earnings per share (EPS) have increased from 0.45 in Mar'21 to 2.47 in Mar'25, showcasing improved shareholder value. Total assets ha..."
      },
      {
        "title": "Why is Walpar Nutrition falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-walpar-nutrition-fallingrising-3699650",
        "imagepath": "",
        "date": "2025-11-13 23:45:09",
        "description": "As of 13-Nov, Walpar Nutritions Ltd is experiencing a price increase, with the current price at 46.65, reflecting a change of 0.75 or 1.63% upward. The stock has outperformed its sector by 1.9% today and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price movement. However, there has been a decline in investor participation, as the delivery volume on November 10 fell by 16.67% compared to the 5-day average. The stock's performance over the past week shows a return of 6.02%, while its 1-month return is 1.41%. Year-to-date, the stock is down 7.62%, contrasting with a 9.45% gain in the benchmark index, Sensex.\n\nIn the broader market context, Walpar Nutritions Ltd's short-term performance has significantly outpaced the Sensex, which has only gained 1.45% over the past week. This indicates that while the stock is currently rising, it has stru..."
      },
      {
        "title": "Is Walpar Nutrition overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-walpar-nutrition-overvalued-or-undervalued-3684236",
        "imagepath": "",
        "date": "2025-11-10 08:13:09",
        "description": "As of 7 November 2025, the valuation grade for Walpar Nutrition has moved from very attractive to attractive, indicating a shift in perception regarding its investment appeal. The company is currently assessed as fairly valued. Key ratios include a PE ratio of 24.45, an EV to EBITDA of 14.02, and a PEG ratio of 0.47, which suggests a reasonable growth outlook relative to its price.\n\nIn comparison to its peers, Walpar Nutrition's valuation appears more favorable. For instance, Hindustan Unilever has a PE ratio of 53.63, and Nestle India stands at 81.21, both categorized as very expensive. This positions Walpar Nutrition as a more attractive option within the FMCG sector. Additionally, while the stock has underperformed the Sensex year-to-date with a return of -12.87% compared to the Sensex's 7.81%, its long-term performance over three years shows a robust return of 54.12%, reinforcing its potential as a soli..."
      },
      {
        "title": "Is Walpar Nutrition overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-walpar-nutrition-overvalued-or-undervalued-3682910",
        "imagepath": "",
        "date": "2025-11-09 08:11:19",
        "description": "As of 7 November 2025, Walpar Nutrition's valuation grade has moved from very attractive to attractive, indicating a shift in its perceived value. The company is currently considered fairly valued. Key ratios include a PE ratio of 24.45, an EV to EBITDA ratio of 14.02, and a PEG ratio of 0.47, which suggest a reasonable valuation relative to its growth prospects.\n\nIn comparison with peers, Walpar Nutrition's PE ratio is significantly lower than that of Hindustan Unilever, which stands at 53.63, and Nestle India at 81.21, both of which are categorized as very expensive. This positions Walpar Nutrition favorably within its industry, especially given its robust ROCE of 18.00% and ROE of 11.26%. Despite a recent decline in stock performance compared to the Sensex, with a year-to-date return of -12.87% versus the Sensex's 7.81%, the company's valuation metrics suggest it remains a solid investment opportunity in..."
      },
      {
        "title": "Is Walpar Nutrition overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-walpar-nutrition-overvalued-or-undervalued-3681927",
        "imagepath": "",
        "date": "2025-11-08 08:11:12",
        "description": "As of 7 November 2025, Walpar Nutrition's valuation grade has moved from very attractive to attractive, indicating a slight shift in its perceived value. The company is currently considered fairly valued. Key ratios include a PE ratio of 24.45, an EV to EBITDA of 14.02, and a PEG ratio of 0.47, which suggests that the stock is reasonably priced relative to its growth potential.\n\nIn comparison to its peers, Walpar Nutrition's PE ratio is significantly lower than that of Hindustan Unilever, which stands at 53.63, and Nestle India, at 81.21, both categorized as very expensive. This positions Walpar Nutrition favorably within the FMCG sector, as it offers a more attractive valuation relative to these leading companies. Despite recent underperformance compared to the Sensex over the year, with a return of -13.73% versus the Sensex's 5.34%, the company's fundamentals suggest it remains a solid investment opportun..."
      },
      {
        "title": "Is Walpar Nutrition overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-walpar-nutrition-overvalued-or-undervalued-3678081",
        "imagepath": "",
        "date": "2025-11-07 08:12:23",
        "description": "As of 6 November 2025, the valuation grade for Walpar Nutrition has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (PE) ratio of 24.45, an EV to EBITDA ratio of 14.02, and a PEG ratio of 0.47, which suggests strong growth potential relative to its price.\n\nIn comparison to its peers, Walpar Nutrition stands out favorably; for instance, Hindustan Unilever has a PE ratio of 54.11 and Nestle India has a PE ratio of 81.85, both categorizing them as very expensive. This positions Walpar Nutrition as a more attractive investment opportunity within the FMCG sector. Notably, while the stock has underperformed the Sensex year-to-date, it has shown a strong return of 54.12% over the past three years, reinforcing its potential for growth...."
      }
    ],
    "total": 77,
    "sid": "1003507",
    "stock_news_url": "https://www.marketsmojo.com/news/walpar-nutritions-1003507"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Walpar Nutritions Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 14 Aug 24",
          "dt": "2024-08-14",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Walpar Nutrition falling/rising?

2025-11-22 01:26:52

Stock Performance Against Benchmarks

Walpar Nutritions has experienced a sustained period of negative returns when compared to the broader Sensex index. Over the past week, the stock has declined by 10.71%, sharply contrasting with the Sensex's modest gain of 0.61%. This underperformance extends over longer horizons as well, with the stock down 14.56% in the last month while the Sensex rose by 0.77%. Year-to-date figures further highlight this divergence, with Walpar Nutritions falling 21.58% against the Sensex's 10.25% gain. Even over a one-year period, the stock remains down 13.91%, whereas the Sensex has appreciated by 11.64%. These figures underscore a persistent weakness in the stock relative to the broader market.

Proximity to 52-Week Low and Technical In...

Read More

Why is Walpar Nutrition falling/rising?

2025-11-18 23:55:24

As of 18-Nov, Walpar Nutritions Ltd is experiencing a decline in its stock price, currently at 42.15, which reflects a decrease of 2.2 or 4.96%. The stock has underperformed its sector by 4.54% today and is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a return of -8.17%, and for the month, it has dropped by 7.87%. Despite a notable increase in delivery volume by 150% on November 14, indicating rising investor participation, the overall performance remains weak, with a year-to-date decline of 16.53%. In the broader market context, the Sensex has shown resilience with a positive return of 0.84% over the past week and 0.78% over the past month, contrasting sharply with Walpar's negative performance. While the stock has outperformed the benchmark over a three-year period with a return of 58.31%, its recent trends suggest a significan...

Read More

Is Walpar Nutrition overvalued or undervalued?

2025-11-18 08:25:16

As of 17 November 2025, the valuation grade for Walpar Nutrition has moved from attractive to very attractive, indicating a strong positive shift in its valuation outlook. The company is currently assessed as undervalued. Key ratios include a PE ratio of 24.64, an EV to EBITDA of 14.13, and a PEG ratio of 0.47, which suggests that the stock is priced favorably relative to its growth prospects. In comparison to its peers, Walpar Nutrition stands out with its lower valuation metrics; for instance, Hindustan Unilever has a PE ratio of 53.89 and an EV to EBITDA of 38.18, while Nestle India shows a PE of 81.88. This positions Walpar Nutrition as a more attractive investment opportunity within the FMCG sector. Despite recent underperformance against the Sensex, with a year-to-date return of -12.18% compared to the Sensex's 10.02%, the company's strong fundamentals and favorable valuation ratios suggest potential...

Read More

How has been the historical performance of Walpar Nutrition?

2025-11-13 23:47:41

Answer: The historical performance of Walpar Nutrition shows significant growth in net sales and profitability over the years. Breakdown: Walpar Nutrition's net sales have increased from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25, demonstrating a robust upward trend. The total operating income followed a similar trajectory, rising from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25. Raw material costs have also escalated, from 4.56 Cr in Mar'21 to 56.89 Cr in Mar'25, reflecting the company's expanding operations. Operating profit (PBDIT) has improved from 0.46 Cr in Mar'21 to 5.99 Cr in Mar'25, while profit before tax has surged from 0.16 Cr to 3.88 Cr during the same period. Profit after tax has risen from 0.15 Cr in Mar'21 to 2.80 Cr in Mar'25, indicating enhanced profitability. The earnings per share (EPS) have increased from 0.45 in Mar'21 to 2.47 in Mar'25, showcasing improved shareholder value. Total assets ha...

Read More

Why is Walpar Nutrition falling/rising?

2025-11-13 23:45:09

As of 13-Nov, Walpar Nutritions Ltd is experiencing a price increase, with the current price at 46.65, reflecting a change of 0.75 or 1.63% upward. The stock has outperformed its sector by 1.9% today and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price movement. However, there has been a decline in investor participation, as the delivery volume on November 10 fell by 16.67% compared to the 5-day average. The stock's performance over the past week shows a return of 6.02%, while its 1-month return is 1.41%. Year-to-date, the stock is down 7.62%, contrasting with a 9.45% gain in the benchmark index, Sensex. In the broader market context, Walpar Nutritions Ltd's short-term performance has significantly outpaced the Sensex, which has only gained 1.45% over the past week. This indicates that while the stock is currently rising, it has stru...

Read More

Is Walpar Nutrition overvalued or undervalued?

2025-11-10 08:13:09

As of 7 November 2025, the valuation grade for Walpar Nutrition has moved from very attractive to attractive, indicating a shift in perception regarding its investment appeal. The company is currently assessed as fairly valued. Key ratios include a PE ratio of 24.45, an EV to EBITDA of 14.02, and a PEG ratio of 0.47, which suggests a reasonable growth outlook relative to its price. In comparison to its peers, Walpar Nutrition's valuation appears more favorable. For instance, Hindustan Unilever has a PE ratio of 53.63, and Nestle India stands at 81.21, both categorized as very expensive. This positions Walpar Nutrition as a more attractive option within the FMCG sector. Additionally, while the stock has underperformed the Sensex year-to-date with a return of -12.87% compared to the Sensex's 7.81%, its long-term performance over three years shows a robust return of 54.12%, reinforcing its potential as a soli...

Read More

Is Walpar Nutrition overvalued or undervalued?

2025-11-09 08:11:19

As of 7 November 2025, Walpar Nutrition's valuation grade has moved from very attractive to attractive, indicating a shift in its perceived value. The company is currently considered fairly valued. Key ratios include a PE ratio of 24.45, an EV to EBITDA ratio of 14.02, and a PEG ratio of 0.47, which suggest a reasonable valuation relative to its growth prospects. In comparison with peers, Walpar Nutrition's PE ratio is significantly lower than that of Hindustan Unilever, which stands at 53.63, and Nestle India at 81.21, both of which are categorized as very expensive. This positions Walpar Nutrition favorably within its industry, especially given its robust ROCE of 18.00% and ROE of 11.26%. Despite a recent decline in stock performance compared to the Sensex, with a year-to-date return of -12.87% versus the Sensex's 7.81%, the company's valuation metrics suggest it remains a solid investment opportunity in...

Read More

Is Walpar Nutrition overvalued or undervalued?

2025-11-08 08:11:12

As of 7 November 2025, Walpar Nutrition's valuation grade has moved from very attractive to attractive, indicating a slight shift in its perceived value. The company is currently considered fairly valued. Key ratios include a PE ratio of 24.45, an EV to EBITDA of 14.02, and a PEG ratio of 0.47, which suggests that the stock is reasonably priced relative to its growth potential. In comparison to its peers, Walpar Nutrition's PE ratio is significantly lower than that of Hindustan Unilever, which stands at 53.63, and Nestle India, at 81.21, both categorized as very expensive. This positions Walpar Nutrition favorably within the FMCG sector, as it offers a more attractive valuation relative to these leading companies. Despite recent underperformance compared to the Sensex over the year, with a return of -13.73% versus the Sensex's 5.34%, the company's fundamentals suggest it remains a solid investment opportun...

Read More

Is Walpar Nutrition overvalued or undervalued?

2025-11-07 08:12:23

As of 6 November 2025, the valuation grade for Walpar Nutrition has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (PE) ratio of 24.45, an EV to EBITDA ratio of 14.02, and a PEG ratio of 0.47, which suggests strong growth potential relative to its price. In comparison to its peers, Walpar Nutrition stands out favorably; for instance, Hindustan Unilever has a PE ratio of 54.11 and Nestle India has a PE ratio of 81.85, both categorizing them as very expensive. This positions Walpar Nutrition as a more attractive investment opportunity within the FMCG sector. Notably, while the stock has underperformed the Sensex year-to-date, it has shown a strong return of 54.12% over the past three years, reinforcing its potential for growth....

Read More

View All News